Stock Research: Arvinas

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Arvinas

NasdaqGS:ARVN US04335A1051
63
  • Value
    74
  • Growth
    9
  • Safety
    Safety
    77
  • Combined
    53
  • Sentiment
    16
  • 360° View
    360° View
    63
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Arvinas, Inc. is a clinical-stage biotechnology company developing protein degradation therapies. The company operates in the biotechnology industry, focusing on developing investigational drugs like vepdegestrant, ARV-393, and ARV-102 for various diseases including breast cancer and neurodegenerative diseases. In the last fiscal year, the company had a market cap of $547 million, $263 million in revenue, and 430 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 63 (better than 63% compared with alternatives), overall professional sentiment and financial characteristics for the stock Arvinas are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Arvinas. The consolidated Value Rank has an attractive rank of 77, which means that the share price of Arvinas is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 77% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 74. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 16. Professional investors are more confident in 84% other stocks. The consolidated Growth Rank also has a low rank of 9, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 91 of its competitors have better growth. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
77 52 14 43
Growth
9 13 69 39
Safety
Safety
74 74 50 59
Sentiment
16 69 65 57
360° View
360° View
63 63 40 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
20 95 89 85
Opinions Change
81 90 66 50
Pro Holdings
n/a 1 49 51
Market Pulse
34 45 26 24
Sentiment
16 69 65 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
77 52 14 43
Growth
9 13 69 39
Safety Safety
74 74 50 59
Combined
53 53 49 40
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
29 29 29 2
Price vs. Earnings (P/E)
59 35 11 9
Price vs. Book (P/B)
81 58 24 69
Dividend Yield
1 1 1 1
Value
77 52 14 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
9 56 23 93
Profit Growth
75 12 47 21
Capital Growth
28 55 76 25
Stock Returns
5 13 73 43
Growth
9 13 69 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
76 66 72 71
Refinancing
99 79 61 77
Liquidity
33 33 1 1
Safety Safety
74 74 50 59

Similar Stocks

Discover high‑ranked alternatives to Arvinas and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.